Look behind the lecture: real-world evidence uses in clinical development to commercialization

In this feature, David Thompson (Syneos Health, NC, USA) discusses his presentation from ISPOR (18–22 May 2019, New Orleans, LA, USA) on the use of real-world evidence (RWE) in the pharmaceutical industry. Could you briefly introduce yourself and describe your current role at Syneos Health? I am a Senior Vice President in the Real World and Late Phase Research (RWLP) Group at Syneos Health (NC, USA). Syneos Health comprises a contract research organization (CRO) as well as what we refer to as a 'contract commercial organization' (CCO). We provide a balance of clinical research and commercialization services, in between which...